|Articles|October 20, 2020

Digital Edition

  • Ophthalmology Times: September 15, 2020
  • Volume 45
  • Issue 15

Options give 1-2 punch to metastatic uveal melanoma

Combining RAF/MEK signaling pathway inhibitor with FAK inhibitor raises bar



This article was reviewed by Justine S. Paradis, PhD

The results of a preclinical study indicate there is hope for an effective treatment for the GNAQ-driven metastatic uveal melanoma, an aggressive form of the disease.

Internal server error